|
REEP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.101450E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.143400E-03 |
| Normal-vs-Stage2 |
1.235410E-01 |
| Normal-vs-Stage3 |
2.217400E-04 |
| Normal-vs-Stage4 |
4.23790000000368E-05 |
| Stage1-vs-Stage2 |
6.771600E-01 |
| Stage1-vs-Stage3 |
3.670000E-02 |
| Stage1-vs-Stage4 |
2.621800E-03 |
| Stage2-vs-Stage3 |
9.611600E-02 |
| Stage2-vs-Stage4 |
4.028300E-02 |
| Stage3-vs-Stage4 |
5.488200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.600900E-03 |
| Normal-vs-AfricanAmerican |
1.17870000004849E-06 |
| Normal-vs-Asian |
4.393400E-01 |
| Caucasian-vs-AfricanAmerican |
4.018200E-04 |
| Caucasian-vs-Asian |
7.197400E-01 |
| AfricanAmerican-vs-Asian |
6.527900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.201170E-03 |
| Normal-vs-Female |
2.284000E-03 |
| Male-vs-Female |
7.971800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.839600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.962200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.212000E-04 |
| Normal-vs-Age(81-100Yrs) |
4.864300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.188200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.333200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.626800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.835810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.014600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.852400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.931800E-01 |
| Normal-vs-Grade 2 |
2.461800E-02 |
| Normal-vs-Grade 3 |
5.90379999999557E-05 |
| Normal-vs-Grade 4 |
4.28599999999779E-05 |
| Grade 1-vs-Grade 2 |
3.199600E-01 |
| Grade 1-vs-Grade 3 |
6.741000E-03 |
| Grade 1-vs-Grade 4 |
7.561700E-03 |
| Grade 2-vs-Grade 3 |
8.993100E-04 |
| Grade 2-vs-Grade 4 |
1.639010E-03 |
| Grade 3-vs-Grade 4 |
4.325600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.461900E-02 |
| Normal-vs-ccB subtype |
1.880850E-03 |
| ccA subtype-vs-ccB subtype |
1.066950E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.117000E-03 |
| Normal-vs-N1 |
2.595800E-02 |
| N0-vs-N1 |
3.023600E-01 |
|
|
